U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

There is one exact (name or code) match for oxyphenonium

 

OXYPHENONIUM

MORE DETAILS

  D2G5508Y7I

Status:
US Previously Marketed
Source:
Antrenyl Bromide by Ciba
(1952)
Source URL:
OB NME Appendix 1950-1985
First approved in 1952
Source:
Antrenyl Bromide by Ciba
Source URL:
OB NME Appendix 1950-1985
Class (Stereo):
CHEMICAL (RACEMIC)
Targets:
Muscarinic acetylcholine receptor
160
Conditions:
Visceral spasms
6
Mydriasis
6
Peptic ulcer
72
Oxyphenonium bromide is a quaternary ammonium anticholinergic agent, which was used under brand name antrenyl, to relieve visceral spasms and as an adjunct in the treatment of peptic ulcer. In addition, Oxyphenonium inhibits gastrointestinal propulsive motility and decreases gastric acid secretion and controls excessive pharyngeal, tracheal and bronchial secretions. Action is achieved via a dual mechanism: a specific anticholinergic effect (antimuscarinic) at the acetylcholine-receptor sites and a direct effect upon smooth muscle. Oxyphenonium bromide also been used in the form of eye drops for mydriatic effec

OXYPHENONIUM

MORE DETAILS

  D2G5508Y7I

Status:
US Previously Marketed
Source:
Antrenyl Bromide by Ciba
(1952)
Source URL:
OB NME Appendix 1950-1985
First approved in 1952
Source:
Antrenyl Bromide by Ciba
Source URL:
OB NME Appendix 1950-1985
Class (Stereo):
CHEMICAL (RACEMIC)
Targets:
Muscarinic acetylcholine receptor
160
Conditions:
Visceral spasms
6
Mydriasis
6
Peptic ulcer
72
Oxyphenonium bromide is a quaternary ammonium anticholinergic agent, which was used under brand name antrenyl, to relieve visceral spasms and as an adjunct in the treatment of peptic ulcer. In addition, Oxyphenonium inhibits gastrointestinal propulsive motility and decreases gastric acid secretion and controls excessive pharyngeal, tracheal and bronchial secretions. Action is achieved via a dual mechanism: a specific anticholinergic effect (antimuscarinic) at the acetylcholine-receptor sites and a direct effect upon smooth muscle. Oxyphenonium bromide also been used in the form of eye drops for mydriatic effec

OXYPHENONIUM BROMIDE

MORE DETAILS

  S9421HWB3Z

Status:
US Previously Marketed
Source:
Antrenyl Bromide by Ciba
(1952)
Source URL:
OB NME Appendix 1950-1985
First approved in 1952
Source:
Antrenyl Bromide by Ciba
Source URL:
OB NME Appendix 1950-1985
Class (Stereo):
CHEMICAL (RACEMIC)
Targets:
Muscarinic acetylcholine receptor
160
Conditions:
Visceral spasms
6
Mydriasis
6
Peptic ulcer
72
Oxyphenonium bromide is a quaternary ammonium anticholinergic agent, which was used under brand name antrenyl, to relieve visceral spasms and as an adjunct in the treatment of peptic ulcer. In addition, Oxyphenonium inhibits gastrointestinal propulsive motility and decreases gastric acid secretion and controls excessive pharyngeal, tracheal and bronchial secretions. Action is achieved via a dual mechanism: a specific anticholinergic effect (antimuscarinic) at the acetylcholine-receptor sites and a direct effect upon smooth muscle. Oxyphenonium bromide also been used in the form of eye drops for mydriatic effec
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966